News

In this letter published in the British Medical Journal, ASPIRE2025 researchers discuss New Zealand’s new Psychoactive Substances Act and say that few of the restrictions in this new act apply to t

A novel trial that has been underway for a month at Queensgate mall in Lower Hutt has seen 256 smokers take up the chance to try nicotine replacement therapy on the spur of the moment.

A novel trial which offers smokers the chance to try nicotine replacement therapy on the spur of the moment as they go about their daily lives has started in Wellington.

The Ministry of Health guidelines for what can be considered ‘outside’ of bars were declared invalid by a court decision in September 2013.

The New Zealand Government is losing up to $89.1 million per annum in tax revenue due to tobacco brought in to the country from overseas, ASPIRE 2025 researchers estimate.

In this NZ Medical Journal letter from ASPIRE2025 researchers George Thomson and Nick Wilson, they discuss the status of the New Zealand’s national smokefree law and the need for an upgrade and exp

A recent ASPIRE2025 study used ASH Y10 data to examine New Zealand adolescents’ support for plain packaging.

To achieve the New Zealand Government’s Smokefree Nation Goal of 2025, the country probably needs major strategies that go beyond business-as-usual.

ASPIRE2025 deputy director, Professor Janet Hoek has received $503,000 to pursue innovative research into smokefree messages as part of a follow-up to the Health Research Council’s (HRC) recent ann

Congratulations to Philip Gendall, Janet Hoek, Damien Mather and Richard Edwards.